A previous study proved that activating the TGF-β1/Smad signaling pathway via SHCBP1 could facilitate metastasis and result in a poor prognosis of synovial sarcoma (Peng et al., 2017). This evidence concerns the gene SHCBP1 and synovial sarcoma.